Molecular Genetic Investigation of Rare Cancers

Dear Colleagues,

Rare cancers are defined by their low incidence and prevalence in different populations. However, these cancers collectively account for more than 20 percent of all cancer diagnoses worldwide. Because of their infrequency, rare cancers are often challenging to diagnose, incompletely understood at the molecular level, and lack specific and effective treatments. The unrealistic need for large sample numbers also hampers many clinical studies. In this Special Issue, we focus on genetic, pathobiologic, and computational studies of molecular changes in rare cancer tissues, cell lines, and disease models. We are particularly interested in novel molecular diagnostic, mechanistic, and therapeutic studies. To overcome a major barrier in rare cancer research, well-performed omics-based small case series or n-of-1 studies are particularly encouraged. A fuller understanding of the molecular basis of rare cancers will advance our knowledge of rare cell biology and improve existing diagnostic and therapeutic approaches for these comparatively neglected cancers.

Dr. Neil Renwick
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• rare cancers
• cancer biology
• molecular diagnostics
• disease mechanisms
• novel therapeutics
• N-of-1 studies